Stay updated on Ralinepag Efficacy in PAH Patients Clinical Trial
Sign up to get notified when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.

Latest updates to the Ralinepag Efficacy in PAH Patients Clinical Trial page
- Check3 days agoChange DetectedAdded numerous new trial sites across multiple countries (Taipei; Valencia; Madrid; Singapore; Porto District; Genova; Foggia; Budapest; Sofia; Córdoba Province; Ciudad Autónoma de Buenos Aires; Buenos Aires; and others) and removed several existing locations, altering the geographic footprint of participating centers.SummaryDifference2%

- Check10 days agoChange DetectedRevision update: v3.4.3 replaces v3.4.2 on the page. No visible changes to study details or page content are apparent.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded 'Heritable pulmonary arterial hypertension' as a related topic/MeSH term in the study's contextual information.SummaryDifference0.0%

- Check24 days agoChange DetectedUpdated the study record with new dates: 2026-02-19 and 2026-02-20 were added, while 2026-02-05 and 2026-02-06 were removed.SummaryDifference0.1%

- Check31 days agoChange Detected- The page now displays Revision: v3.4.2, replacing the previous v3.4.1. This is a minor metadata update and does not alter study content or results.SummaryDifference0.0%

- Check38 days agoChange DetectedNew trial sites were added across Argentina, Bulgaria, France, Hungary, Italy, Portugal, Singapore, Spain, and Taiwan, and many previously listed locations were removed.SummaryDifference2%

Stay in the know with updates to Ralinepag Efficacy in PAH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ralinepag Efficacy in PAH Patients Clinical Trial page.